Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Screening for Primary Aldosteronism: Effect of Test and Cutoff Level on Positivity Rate

AHA Hypertension Scientific Sessions 2024 

American Heart Association

Chicago, Il, Sep 5-8, 2024

Poster presentation: Screening for Primary Aldosteronism: Effect of Test and Cutoff Level on Positivity Rate

Authors: Marcelli M, Funder JW, Bi C, McPhaul MJ

Specialty: Cardiology, Endocrinology

Related content

Publication
Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism
Conference Presentation
The diagnosis of primary aldosteronism: testing 2 screening approaches in a large reference laboratory population
Conference Presentation
Positivity Rates of Screening Criteria for Primary Aldosteronism: A Cohort Comparison Study
On-Demand Webinar
Utilizing Apolipoprotein B in Cardiovascular Risk Assessment
On-Demand Webinar
Utilizing Lipoprotein(a) in Cardiovascular Risk Assessment
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.